Quick Answer
Bluejay Diagnostics, Inc. reported Stockholders Equity of $5.98 million for fiscal year 2025.
Bluejay Diagnostics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $5.98M | +4.3% |
| 2024 | $5.73M | +97.9% |
| 2023 | $2.89M | -74.9% |
| 2022 | $11.54M | -43.4% |
| 2021 | $20.38M | +584.6% |
| 2020 | -$4.21M | -43.4% |
| 2019 | -$2.93M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.69M | -48.5% | -30.2% |
| June 30, 2025 | $5.29M | -38.8% | +36.8% |
| March 31, 2025 | $3.87M | +14.8% | -32.5% |
| December 31, 2024 | $5.73M | +97.9% | -20.0% |
| September 30, 2024 | $7.16M | +37.4% | -17.1% |
| June 30, 2024 | $8.64M | +35.5% | +156.6% |
| March 31, 2024 | $3.37M | -63.3% | +16.3% |
| December 31, 2023 | $2.89M | -74.9% | -44.5% |
- Bluejay Diagnostics, Inc. showed an increase of +4.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Bluejay Diagnostics, Inc.’s stockholders equity has grown by 303.8% (from -$2.93 million to $5.98 million).
- The most recent figure is from Bluejay Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: